Health Global Access Project, Inc.

Today, we're...

1) Fighting for Full Funding to Defeat AIDS by 2030: At this pivotal moment where ending the AIDS epidemic is finally within reach, politicians lack the political will to increase funding for HIV treatment and prevention. In this era of austerity budgeting, Health GAP is one of the few organizations fighting boldly for the expanded investment needed to seize this opportunity to end the epidemic.

2) Supporting Activists Speaking Truth to Power: Health GAP supports activists in the U.S. and around the world because there is no substitute for people with HIV and their communities demanding action from powerful decision makers and being at the table to plan national HIV responses.

3) Working to End Treatment Inequity: We work tirelessly with activist partners to ensure rapid implementation of life-saving scientific evidence, such as the recent WHO recommendation that all people with HIV should have access to treatment, regardless of their disease stage.

4) Challenging Pharma Greed, High Drug Prices, and Harmful Trade Rules: We campaign for access to innovative and affordable medicines by fighting back against attempts by governments and pharmaceutical corporations to obstruct cost-cutting generic competition.

5) Securing Health Justice: Health GAP is applying lessons learned from AIDS activism to interconnected health justice campaigns. In particular, we work with key allies to campaign for laws and policies to end unsafe abortion, and we work to win health rights for criminalized and excluded populations such as men who have sex with men, people who use drugs, and sex workers.

The stakes have always been high for people living with HIV, but under the Trump administration, they've reached red alert status. Trump's first budget proposes more than $1 billion in cuts to global AIDS treatment and prevention programs -- cuts that some experts say could kill more than 1 million people. To meet this challenge, we're dramatically expanding grassroots power to fight for the funding and policies needed to save lives and end the AIDS epidemic.

Over the past 19 years, we have successfully driven down the costs of antiretroviral medicines, played critical roles in winning new donor initiatives to support HIV treatment scale-up - such as the United States' President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria - and worked shoulder to shoulder with dozens of organizations in the Global South to increase access to treatment and prevention services that meet the needs of people living with and affected by HIV.

Over the past 19 years, we have successfully driven down the costs of antiretroviral medicines, played critical roles in winning new donor initiatives to support HIV treatment scale-up - such as the United States' President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria - and worked shoulder to shoulder with dozens of organizations in the Global South to increase access to treatment and prevention services that meet the needs of people living with and affected by HIV.